David A. Finkelstein
Gründer bei Path Systems, Inc.
Profil
David A.
Finkelstein has been Chief Strategy Officer of Interleukin Genetics, Inc. since August 17, 2006.
Prior to joining Interleukin, he had been Chief Operating Officer and Founder of the Alan James Group LLC since 2002.
Prior to founding Alan James Group, Mr. Finkelstein was the Founder of Fusive.com Corp.
He received a BSME from the University of Vermont and an MBA from York University, Toronto, Canada.
Aktive Positionen von David A. Finkelstein
| Unternehmen | Position | Beginn |
|---|---|---|
| Path Systems, Inc. | Gründer | 03.06.2010 |
| Reference Media Corp. | Gründer | 03.06.2010 |
Ehemalige bekannte Positionen von David A. Finkelstein
| Unternehmen | Position | Ende |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 02.07.2007 |
Ausbildung von David A. Finkelstein
| York University | Masters Business Admin |
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
| Path Systems, Inc. | |
| Reference Media Corp. |
